BioPharm International
September 01, 2006
Columns and Departments
19
9
In case you haven't heard, Jeffrey Kindler, Pfizer's general counsel, is replacing long-time CEO Henry "Hank" McKinnell as the new head of the company. There is a long-range strategy in naming a lawyer to run a drug company and I'll get to that in a moment.
September 01, 2006
Columns and Departments
19
9
Taking a purist stance is always tempting. It can, however, have unintended consequences.
September 01, 2006
Articles
19
9
Companies faced with real or threatened FDA sanctions are usually least prepared to react effectively.
September 01, 2006
Columns and Departments
19
9
Better supplier management can begin in parallel to production-related improvements.
September 01, 2006
Featured Article
19
9
Steam traps are part of a steam-in-place system. The current design allots 18 in. of vertical leg for condensate backup. A design with a sensitive bellows has been proven in laboratory tests to need only 6 in. of vertical leg during the 15 min. of 121?C sterilization. Loads of 1 to 27 lb/h are covered by the capability of the new trap, equivalent to required steam for vessels 20 to 40,000 L.
September 01, 2006
Articles
19
9
Increasingly, pharmaceutical companies have recognized that software development is not their core competency.
September 01, 2006
Articles
19
9
Good risk management tools dictate how much assay performance characteristics can deviate from ideal.
September 01, 2006
Columns and Departments
19
9
There is growing support for new partnership arrangements that seek to expand drug research by reducing the financial risk for manufacturers.
September 01, 2006
Articles
19
9
China is becoming a much more sophisticated economy, with a large and well-educated workforce.